One-Month SOFR Futures (SR1 July 2024)/ XFTTSR1CMEGL / CME GLOBEX
SR1| 2024-06-28 10:59:57 PM | Chg. +0.0050 | Bid11:50:02 PM | Ask11:50:02 PM | Open | High | Low | Previous Close |
|---|---|---|---|---|---|---|---|
| 94.6800USD | +0.01% | 94.6750 | 94.6800 | 94.6750 | 94.6800 | 94.6750 | 94.6750 |
GlobeNewswire
06-10
Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire
06-06
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
Newsfile Corp
06-06
First Fence Enhances Property Security with LPS 1175 Rated ProFence(R) SR1 System
GlobeNewswire
05-30
Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire
04-29
Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...
GlobeNewswire
2023-12-12
Sermonix Pharmaceuticals Shares Pharmacokinetic and Baseline Genomic Clinical Data Tied to ELAINE La...
GlobeNewswire
2023-12-12
Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient...
GlobeNewswire
2023-11-06
Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete R...
GlobeNewswire
2021-12-13
Sermonix Pharmaceuticals Announces Poster Presentation at the 2021 San Antonio Breast Cancer Symposi...
GlobeNewswire
2021-11-15
Sermonix Pharmaceuticals Closes $40 Million Series A3 Financing Round Led by Perceptive Xontogeny Ve...
GlobeNewswire
2021-08-16
Sermonix Pharmaceuticals Completes Enrollment of Phase 2 ELAINE 1 Randomized Clinical Trial Assessin...
GlobeNewswire
2021-06-28
Sermonix Pharmaceuticals Completes Enrollment of Phase 2 Clinical Trial Collaboration Studying Lasof...
GlobeNewswire
2021-04-21
Sermonix Pharmaceuticals Project With Huntsman Cancer Institute Researcher to Investigate Potential ...
GlobeNewswire
2020-12-03
Sermonix to Present Poster on Phase 2 Study of Lasofoxifene in Combination with Eli Lilly and Compan...
GlobeNewswire
2020-10-13
Sermonix Doses First Patient in Phase 2 Clinical Trial Collaboration Studying Lasofoxifene in Combin...
GlobeNewswire
2020-09-30
Sermonix Pharmaceuticals Partners With Exactis Innovation for ELAINE 1 Clinical Trial Sites in Canad...
GlobeNewswire
2020-07-08
Sermonix Pharmaceuticals to Collaborate With Eli Lilly and Company in Studying Combination of Lasofo...
GlobeNewswire
2019-09-25
Sermonix to Present Poster on Oncologists’ Perception of Sexual Intimacy Issues in Treatment of Meta...
GlobeNewswire
2019-09-23
Sermonix Doses First Patient in Phase 2 Clinical Trial of Lasofoxifene for Targeted Precision Medici...
GlobeNewswire
2019-07-31
Sermonix Pharmaceuticals Closes US$26 Million Series A Financing Round Led by WILD Family Office
GlobeNewswire
2019-06-03
Sermonix Poster Presentation at 2019 ASCO Annual Meeting Demonstrates Promise for Lasofoxifene in Tr...
GlobeNewswire
2019-05-28
Sermonix Receives FDA Fast Track Designation for Investigational Drug Lasofoxifene
GlobeNewswire
2019-05-07
Sermonix to Present Poster on ‘Lasofoxifene as a Potential Treatment for ER+ Metastatic Breast Cance...
